Forbes August 23, 2024
John Werner

Modern treatments for depression have been evolving throughout the past few decades.

In the historical context, it wasn’t long ago when hospitals were performing lobotomies on patients, but these days, that seems like the stuff of a horror film; deeply intrusive, damaging to the brain tissue, and comparatively primitive.

Since the 1940s, the common treatment became electroconvulsive therapy, which could lead to seizures and had a dramatic impact on the brain’s overall function, sometimes with deep side effects that, again, inspire a sense of terror.

Since its invention in 1985, and 2008 FDA approval for severe, or treatment resistant depression (TRD), more recently, there is a non-invasive process called Transcranial Magnetic Stimulation or TMS. In this method, Doctors place a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Medical Devices, Technology
Phillips launches updated AI tech for MRI scanners
Medtronic partners with Brainomix on AI stroke tool
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Share This Article